Structure-based discovery of potent and selective melatonin receptor agonists
Melatonin receptors MT1 and MT2 are involved in synchronizing circadian rhythms and are
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
Structure-based discovery of potent and selective melatonin receptor agonists
N Patel, XP Huang, JM Grandner, LC Johansson… - eLife, 2020 - cdr.lib.unc.edu
Melatonin receptors MT1 and MT2 are involved in synchronizing circadian rhythms and are
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
Structure-based discovery of potent and selective melatonin receptor agonists.
N Patel, XP Huang, JM Grandner, LC Johansson… - Elife, 2020 - europepmc.org
Melatonin receptors MT 1 and MT 2 are involved in synchronizing circadian rhythms and are
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
Structure-based discovery of potent and selective melatonin receptor agonists
N Patel, XP Huang, JM Grandner, LC Johansson… - eLife, 2020 - cir.nii.ac.jp
抄録< jats: p> Melatonin receptors MT1 and MT2 are involved in synchronizing circadian
rhythms and are important targets for treating sleep and mood disorders, type-2 diabetes …
rhythms and are important targets for treating sleep and mood disorders, type-2 diabetes …
Structure-based discovery of potent and selective melatonin receptor agonists
N Patel, XP Huang, JM Grandner, LC Johansson… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Melatonin receptors MT 1 and MT 2 are involved in synchronizing circadian rhythms and are
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
Structure-based discovery of potent and selective melatonin receptor agonists
P Nilkanth, XP Huang, JM Grandner, LC Johansson… - eLife, 2020 - search.proquest.com
Melatonin receptors MT 1 and MT 2 are involved in synchronizing circadian rhythms and are
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
[HTML][HTML] Structure-based discovery of potent and selective melatonin receptor agonists
N Patel, XP Huang, JM Grandner, LC Johansson… - eLife, 2020 - ncbi.nlm.nih.gov
Melatonin receptors MT 1 and MT 2 are involved in synchronizing circadian rhythms and are
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
Structure-based discovery of potent and selective melatonin receptor agonists
N Patel, XP Huang, JM Grandner, LC Johansson… - 2020 - agris.fao.org
Melatonin receptors MT1 and MT2 are involved in synchronizing circadian rhythms and are
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
important targets for treating sleep and mood disorders, type-2 diabetes and cancer. Here …
[引用][C] Structure-based discovery of potent and selective melatonin receptor agonists
N Patel, JM Grandner, LC Johansson, B Stauch… - eLife, 2020 - elibrary.ru